Lepu Biopharma Co., Ltd.
Clinical trials sponsored by Lepu Biopharma Co., Ltd., explained in plain language.
-
Virus therapy targets tough bladder cancer after standard treatment fails
Disease control Recruiting nowThis study is testing a new treatment called cretostimogene grenadenorepvec for people with high-risk bladder cancer that hasn't responded to standard BCG therapy. The treatment involves putting a modified virus directly into the bladder to try to kill cancer cells. Researchers w…
Phase: PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 23:11 UTC
-
New cancer drug enters human testing: could it control advanced tumors?
Disease control Recruiting nowThis early-stage clinical trial is testing a new drug called MRG006A in people with advanced solid tumors that have stopped responding to standard treatments. The study aims to find the safest and most effective dose and see if the drug can help shrink tumors. Researchers will en…
Phase: PHASE1, PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC